ArticleMolecular cancer therapeutics2024

Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors.

Amy E Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.